about
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX...
Read More
3.57
0.06
(1.71%)
2,031
XNAS Volume
XNAS 16 Jul, 2025 10:35 AM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
enGene Holdings Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..